Profile
Ian Garland is currently a Director at Ligand UK Development Ltd. He was previously the Chief Executive Officer & Executive Director at Ligand UK Ltd. from 2012 to 2018.
He was also the Chief Executive Officer at Acambis Plc in 2007, and a Director at Vernalis (R&D) Ltd. from 2009 to 2018.
Additionally, he was the Chief Financial Officer at Amarin Corp.
Plc in 2003, and a Principal at KPMG LLP from 1988 to 1995.
He was also a Principal at Pepsi-Cola North America from 1995 to 1999, and a Chief Financial Officer at Arrow Therapeutics Ltd. from 2004 to 2007.
Furthermore, he was a Principal at Medeva Plc from 1995 to 1999, and the President & Chief Operating Officer at Celltech Pharma Europe Ltd.
Ian Garland active positions
| Companies | Position | Start |
|---|---|---|
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Former positions of Ian Garland
| Companies | Position | End |
|---|---|---|
| VERNALIS | Chief Executive Officer | 11/10/2018 |
Vernalis (R&D) Ltd.
Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company | Director/Board Member | 11/10/2018 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines | President | 31/08/2008 |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director of Finance/CFO | 31/12/2006 |
| AMARIN CORPORATION PLC | Director of Finance/CFO | 31/12/2003 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Ligand UK Ltd.
Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pepsi-Cola North America
Pepsi-Cola North America Beverages: Non-AlcoholicConsumer Non-Durables Manufactures and markets beverage products | Consumer Non-Durables |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Medeva Plc
Medeva Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company for the development, manufacture and sale of pharmaceutical products | Health Technology |
Vernalis (R&D) Ltd.
Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company | Health Technology |
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Celltech Pharma Europe Ltd. |
- Stock Market
- Insiders
- Ian Garland
















